Teachers Advisors’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

Teachers Advisors’s Portfolio GTHX Stock Details GTHX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$827K	Buy	49,821 +4,886	+11%	+$92.7K	﹤0.01%	2363
2018 Q4	$861K	Buy	44,935 +2,348	+6%	+$87.9K	﹤0.01%	2264
2018 Q3	$2.23M	Buy	42,587 +1,944	+5%	+$106K	﹤0.01%	1921
2018 Q2	$1.77M	Buy	40,643 +16,063	+65%	+$688K	﹤0.01%	2022
2018 Q1	$911K	Buy	24,580 +10,762	+78%	+$287K	﹤0.01%	2255
2017 Q4	$274K	Buy	13,818 +4,260	+45%	+$91.6K	﹤0.01%	2837
2017 Q3	$238K	Buy	+9,558	New	+$177K	﹤0.01%	2929

Other funds holding GTHX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Teachers Advisors's GTHX Position: Q1 2019 in Review

Teachers Advisors increased its G1 Therapeutics, Inc. Common Stock (GTHX) stake by 11% in Q1 2019, buying an estimated $92.7K and bringing the position to 49,821 shares worth $827K. The position accounts for ﹤0.01% of the portfolio, ranked #2363.

Teachers Advisors first reported a position in GTHX in Q3 2017 and has held it in 7 quarters since. The position peaked at $2.23M in Q3 2018. 93 funds tracked by Wall St. Rank hold GTHX as of Q1 2019.

Teachers Advisors held 49,821 shares of G1 Therapeutics, Inc. Common Stock worth $827K as of Q1 2019.
Teachers Advisors bought 4,886 G1 Therapeutics, Inc. Common Stock shares in Q1 2019, an estimated $92.7K.
G1 Therapeutics, Inc. Common Stock made up ﹤0.01% of Teachers Advisors's portfolio in Q1 2019, its #2363 holding.
Teachers Advisors first reported a position in G1 Therapeutics, Inc. Common Stock in Q3 2017 and has held it in 7 quarters since.
Teachers Advisors's G1 Therapeutics, Inc. Common Stock position peaked at $2.23M in Q3 2018.
93 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q1 2019.

Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.